Aldose reductase inhibitors and the complications of diabetes mellitus

Diabet Med. 1993 Apr;10(3):214-30. doi: 10.1111/j.1464-5491.1993.tb00049.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Aldehyde Reductase / antagonists & inhibitors*
  • Aldehyde Reductase / metabolism
  • Animals
  • Cataract / drug therapy*
  • Cataract / metabolism
  • Diabetes Complications
  • Diabetes Mellitus / metabolism*
  • Diabetes Mellitus, Experimental / drug therapy
  • Diabetes Mellitus, Experimental / enzymology
  • Diabetic Angiopathies / drug therapy*
  • Diabetic Angiopathies / enzymology
  • Diabetic Angiopathies / physiopathology
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / enzymology
  • Diabetic Nephropathies / physiopathology
  • Diabetic Neuropathies / drug therapy*
  • Diabetic Neuropathies / enzymology
  • Diabetic Neuropathies / physiopathology
  • Diabetic Retinopathy / drug therapy*
  • Diabetic Retinopathy / metabolism
  • Humans
  • Kidney / enzymology
  • Naphthalenes / therapeutic use*
  • Rats

Substances

  • Naphthalenes
  • tolrestat
  • Aldehyde Reductase